Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 6/20 | 0.48 |
| ▸ | KDM1A | O60341 | 4/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26314441 | 0.76 | IDO1 (0.66) | IDO1KDM1ATDO2KMT2AEPAS1 | |
| SCHEMBL26314449 | 0.73 | IDO1 (0.45) | IDO1KDM1ATDO2KMT2AEPAS1 | |
| SCHEMBL26314443 | 0.73 | IDO1 (0.44) | IDO1KDM1ATDO2KMT2AEPAS1 | |
| SCHEMBL26314448 | 0.72 | IDO1 (0.60) | IDO1KDM1ATDO2KMT2AEPAS1 | |
| SCHEMBL15447095 | 0.66 | IDO1 (1.00) | IDO1KDM1ATDO2EPAS1GPR3 | |
| SCHEMBL11561685 | 0.64 | IDO1 (0.62) | IDO1KDM1ATDO2KMT2AEPAS1 | |
| SCHEMBL13654810 | 0.61 | ALDH1A1 (0.72) | KMT2AMEN1MAPTCASP3RAB9A | |
| SCHEMBL15443296 | 0.60 | IDO1 (0.55) | IDO1KDM1ATDO2KMT2AMEN1 | |
| SCHEMBL23514221 | 0.59 | IDO1 (0.62) | IDO1KDM1ATDO2EPAS1MAPT | |
| SCHEMBL1922099 | 0.59 | KDM1A (0.70) | IDO1KDM1AKMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263058-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263058-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | NR2E3, LGR4, NCOA4 | IDO1 2191/4885KDM1A 1796/4885TDO2 939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.